Blog
RSS FeedPosted by Michael Wonder on 27 Sep 2017
Mother of three's life has $5900 a month price tag
24 September 2017 - Imagine having a price tag on your life. For Rebekah Sands-Cade it's $5900 a month. ...
Posted by Michael Wonder on 26 Sep 2017
Agenda for 27 September TC meeting
25 September 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 26 Sep 2017
Final budget outcomes reveal industry efforts to take pressure off PBS
26 September 2017 - The Final Budget Outcome papers released today reveal the enormous efforts of the members of Medicines ...
Posted by Michael Wonder on 26 Sep 2017
'Miracle drug' Keytruda should be funded, patients say
26 September 2017 - A 44-year-old father of four given six to nine months to live when he was diagnosed ...
Posted by Michael Wonder on 26 Sep 2017
Drugs watchdog NICE attacks pharmaceutical industry in pricing dispute
25 September 2017 - Industry expert’s evidence is not independent, NICE argues. ...
Posted by Michael Wonder on 26 Sep 2017
TGA and PBAC parallel process now available for vaccines
26 September 2017 - Vaccines that meet certain requirements are now eligible to be submitted under the TGA and PBAC ...
Posted by Michael Wonder on 26 Sep 2017
PBS cost recovery implementation statement (2017-2018)
26 September 2017 - The PBS cost recovery implementation statement for 1 July 2017 – 30 June 2018 is now available. ...
Posted by Michael Wonder on 25 Sep 2017
NICE nod for new Eylea indication
22 September 2017 - NICE has issued a final positive recommendation for Bayer’s Eylea as a treatment for adults for ...
Posted by Michael Wonder on 25 Sep 2017
First-in-class BRCA-positive ovarian cancer medicine Lynparza (olaparib) receives positive pan-Canadian Oncology Drug Review recommendation for provincial reimbursement
21 September 2017 - This marks an important first step towards providing Canadian women with access to this treatment. ...
Posted by Michael Wonder on 22 Sep 2017
New fact sheets - infliximab biosimilars
22 September 2017 - Fact sheets about infliximab biosimilars for consumers and health care professionals are now available on the Department ...
Posted by Michael Wonder on 20 Sep 2017
3.6 million Kiwis benefit from PHARMAC's model
20 September 2017 - Health Minister Jonathan Coleman says new data shows that PHARMAC is delivering more subsidised medicines, benefiting ...
Posted by Michael Wonder on 20 Sep 2017
Nivolumab now available for lung cancer after company offers NICE new CDF deal
20 September 2017 - Around 1,300 lung cancer patients will receive nivolumab as part of a CDF deal put forward ...
Posted by Michael Wonder on 18 Sep 2017
NICE rejects first-line use of Roche’s Gazyvaro
18 September 2017 - The National Institute for Health and Care Excellence has turned down first-line use of Roche’s Gazyvaro ...
Posted by Michael Wonder on 17 Sep 2017
Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples
13 September 2017 - Organisations such as the NICE require the synthesis of evidence from existing studies to inform their decisions—for ...
Posted by Michael Wonder on 17 Sep 2017
Cystic fibrosis sufferers put their hope in a change of Government
17 September 2017 - The parents of a 12-year-old boy who suffers from cystic fibrosis say a Labour victory is ...